Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 114

1.

Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay.

De Robertis R, Paiella S, Cardobi N, Landoni L, Tinazzi Martini P, Ortolani S, De Marchi G, Gobbo S, Giardino A, Butturini G, Tortora G, Bassi C, D'Onofrio M.

Abdom Radiol (NY). 2017 Jul 4. doi: 10.1007/s00261-017-1243-z. [Epub ahead of print] Review.

PMID:
28677005
2.

Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment.

D'Onofrio M, Cingarlini S, Ortolani S, Crosara S, DE Robertis R, Vallerio P, Grego E, Ciaravino V, Ruzzenente A, Landoni L, Scarpa A, Bassi C, Tortora G.

Anticancer Res. 2017 Mar;37(3):1305-1311.

PMID:
28314296
3.

Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage.

De Robertis R, Cingarlini S, Tinazzi Martini P, Ortolani S, Butturini G, Landoni L, Regi P, Girelli R, Capelli P, Gobbo S, Tortora G, Scarpa A, Pederzoli P, D'Onofrio M.

World J Gastroenterol. 2017 Jan 14;23(2):275-285. doi: 10.3748/wjg.v23.i2.275.

4.

Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report.

Ciccarese C, Ferrara R, Fantinel E, Zecchetto C, Simionato F, Grego E, Ortolani S, Caccese M, Bimbatti D, Cingarlini S, Brunelli M, Andreini A, Tortora G, Massari F.

Future Sci OA. 2015 Nov 1;1(4):FSO29. doi: 10.4155/fso.15.27. eCollection 2015 Nov.

5.

Role of Combined 68Ga-DOTATOC and 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors: Implications for Managing Surgical Decisions.

Cingarlini S, Ortolani S, Salgarello M, Butturini G, Malpaga A, Malfatti V, DʼOnofrio M, Davì MV, Vallerio P, Ruzzenente A, Capelli P, Citton E, Grego E, Trentin C, De Robertis R, Scarpa A, Bassi C, Tortora G.

Pancreas. 2017 Jan;46(1):42-47.

PMID:
27906872
6.

Digital Subtraction of Magnetic Resonance Images Improves Detection and Characterization of Pancreatic Neuroendocrine Neoplasms.

De Robertis R, Tinazzi Martini P, Cingarlini S, Ortolani S, Butturini G, Regi P, Landoni L, Tortora G, Pederzoli P, D'Onofrio M.

J Comput Assist Tomogr. 2017 Jul/Aug;41(4):614-618. doi: 10.1097/RCT.0000000000000552.

PMID:
27861198
7.

Update on medical treatment of small intestinal neuroendocrine tumors.

Pusceddu S, Femia D, Lo Russo G, Ortolani S, Milione M, Maccauro M, Vernieri C, Prinzi N, Concas L, Leuzzi L, De Braud F, Buzzoni R.

Expert Rev Anticancer Ther. 2016 Sep;16(9):969-76. doi: 10.1080/14737140.2016.1207534. Epub 2016 Jul 13. Review.

PMID:
27353232
8.

The Italian Observational Study on Severe Osteoporosis (ISSO): 24-month results on incidence of fractures and adherence to treatment.

Idolazzi L, Maugeri D, Monti S, Massarotti M, Osella G, Barbagallo M, Del Fiacco R, Silvestri S; ISSO Study Group.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):247-53. Epub 2016 Feb 26.

PMID:
26940788
9.

High Kellgren-Lawrence Grade and Bone Marrow Lesions Predict Worsening Rates of Radiographic Joint Space Narrowing; The SEKOIA Study.

Edwards MH, Parsons C, Bruyère O, Petit Dop F, Chapurlat R, Roemer FW, Guermazi A, Zaim S, Genant H, Reginster JY, Dennison EM, Cooper C; SEKOIA Study Group.

J Rheumatol. 2016 Mar;43(3):657-65. doi: 10.3899/jrheum.150053. Epub 2016 Jan 15.

PMID:
26773120
10.

Pancreatic Neuroendocrine Neoplasms: Clinical Value of Diffusion-Weighted Imaging.

De Robertis R, D'Onofrio M, Zamboni G, Tinazzi Martini P, Gobbo S, Capelli P, Butturini G, Girelli R, Ortolani S, Cingarlini S, Pederzoli P, Scarpa A.

Neuroendocrinology. 2016;103(6):758-70. doi: 10.1159/000442984. Epub 2015 Dec 9.

PMID:
26646652
11.

Prognostication and response assessment in liver and pancreatic tumors: The new imaging.

De Robertis R, Tinazzi Martini P, Demozzi E, Puntel G, Ortolani S, Cingarlini S, Ruzzenente A, Guglielmi A, Tortora G, Bassi C, Pederzoli P, D'Onofrio M.

World J Gastroenterol. 2015 Jun 14;21(22):6794-808. doi: 10.3748/wjg.v21.i22.6794. Review.

12.

Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives.

Ortolani S, Ciccarese C, Cingarlini S, Tortora G, Massari F.

Future Oncol. 2015;11(12):1809-28. doi: 10.2217/fon.15.81. Review.

PMID:
26075448
13.

Physical exercise and sarcopenia in older people: position paper of the Italian Society of Orthopaedics and Medicine (OrtoMed).

Iolascon G, Di Pietro G, Gimigliano F, Mauro GL, Moretti A, Giamattei MT, Ortolani S, Tarantino U, Brandi ML.

Clin Cases Miner Bone Metab. 2014 Sep;11(3):215-21.

14.

Worldwide uptake of FRAX.

Kanis JA, Johansson H, Oden A, Cooper C, McCloskey EV; Epidemiology and Quality of Life Working Group of IOF.

Arch Osteoporos. 2014;9:166. doi: 10.1007/s11657-013-0166-8. Epub 2014 Jan 14.

PMID:
24420978
15.

Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF.

Kanis JA, Adachi JD, Cooper C, Clark P, Cummings SR, Diaz-Curiel M, Harvey N, Hiligsmann M, Papaioannou A, Pierroz DD, Silverman SL, Szulc P; Epidemiology and Quality of Life Working Group of IOF.

Osteoporos Int. 2013 Nov;24(11):2763-4. doi: 10.1007/s00198-013-2413-7. Epub 2013 Jul 25.

16.

When the government actively faces the burden of osteoporosis: the Italian experience.

Brandi ML, Guglielmi G, Masala S, Minisola S, Ortolani S, Tarantino U, Simonetti G.

Arch Osteoporos. 2012;7:21-4. doi: 10.1007/s11657-012-0077-0. Epub 2012 Jul 26.

PMID:
23225277
17.

A systematic review of hip fracture incidence and probability of fracture worldwide.

Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA, Cooper C; IOF Working Group on Epidemiology and Quality of Life.

Osteoporos Int. 2012 Sep;23(9):2239-56. Epub 2012 Mar 15. Review.

18.

Official Positions for FRAX® clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.

Cauley JA, El-Hajj Fuleihan G, Arabi A, Fujiwara S, Ragi-Eis S, Calderon A, Chionh SB, Chen Z, Curtis JR, Danielson ME, Hanley DA, Kroger H, Kung AW, Lesnyak O, Nieves J, Pluskiewicz W, El Rassi R, Silverman S, Schott AM, Rizzoli R, Luckey M; FRAX(®) Position Conference Members.

J Clin Densitom. 2011 Jul-Sep;14(3):240-62. doi: 10.1016/j.jocd.2011.05.015.

PMID:
21810532
19.

FRAX® International Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference.

Cauley JA, El-Hajj Fuleihan G, Luckey MM; FRAX(®) Position Development Conference Members.

J Clin Densitom. 2011 Jul-Sep;14(3):237-9. doi: 10.1016/j.jocd.2011.05.016.

PMID:
21810531
20.

Official Positions for FRAX® Bone Mineral Density and FRAX® simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.

Lewiecki EM, Compston JE, Miller PD, Adachi JD, Adams JE, Leslie WD, Kanis JA, Moayyeri A, Adler RA, Hans DB, Kendler DL, Diez-Perez A, Krieg MA, Masri BK, Lorenc RR, Bauer DC, Blake GM, Josse RG, Clark P, Khan AA; FRAX® Position Development Conference Members.

J Clin Densitom. 2011 Jul-Sep;14(3):226-36. doi: 10.1016/j.jocd.2011.05.017.

PMID:
21810530

Supplemental Content

Loading ...
Support Center